EAM
LEGN icon

Erste Asset Management’s Legend Biotech LEGN Stock Holding History

Erste Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-34,700
Closed -$2.08M – 555
2023
Q4 		$2.08M Hold
34,700
– – 0.03% 295
2023
Q3 		$2.34M Buy
34,700
+25,000
+258% +$1.74M 0.04% 260
2023
Q2 		$681K Hold
9,700
– – 0.01% 394
2023
Q1 		$466K Hold
9,700
– – 0.01% 426
2022
Q4 		$482K Hold
9,700
– – 0.01% 427
2022
Q3 		$389K Hold
9,700
– – 0.01% 444
2022
Q2 		$528K Hold
9,700
– – 0.01% 423
2022
Q1 		$358K Buy
+9,700
New +$383K 0.01% 464

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Erste Asset Management's LEGN Position: Q1 2024 in Review

Erste Asset Management sold out of Legend Biotech (LEGN) in Q1 2024, closing a stake of 34,700 shares — an estimated $2.08M sold.

Erste Asset Management first reported a position in LEGN in Q1 2022 and held it in 8 quarters. The position peaked at $2.34M in Q3 2023. 192 funds tracked by Wall St. Rank hold LEGN as of Q1 2024.

  • Erste Asset Management reported no remaining Legend Biotech position as of Q1 2024 after selling out during the quarter.
  • Erste Asset Management sold 34,700 Legend Biotech shares in Q1 2024, an estimated $2.08M.
  • Erste Asset Management first reported a position in Legend Biotech in Q1 2022 and held it in 8 quarters.
  • Erste Asset Management's Legend Biotech position peaked at $2.34M in Q3 2023.
  • 192 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2024.

Based on Erste Asset Management's 13F filing for Q1 2024, filed 26 Nov 2024.